Key facts
- Whitehead scientist Jonathan Weissman co-led the CHARM work with Sonia Vallabh of the Broad.
- Co-first authors Edwin Neumann (graduate student) and Tessa Bertozzi (postdoc) are from the Weissman lab.
- A single intravenous AAV dose eliminated more than 80 percent of brain PrP in mice and the paper appeared in Science on 28 June 2024.
- The CHARM design replaces Cas9 with a zinc finger protein and recruits the cell's own DNMT3A, with a self-silencing feature.
- Delivery across the mouse brain depends on an engineered AAV capsid from the Broad lab of Ben Deverman.
Timeline
- 2024Deverman lab delivery vector published.
- 2024CHARM published in Science.